Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence
This study has been terminated.
( Negative pharmacodynamics due to lack of Interleukin-13 signature in biomarker data from Part I of the study. )
Study NCT00987545 Information provided by Novartis
First Received on September 30, 2009. Last Updated on May 2, 2012
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Connective Tissue Diseases
Interventions listed in this trial
Sponsors listed in this trial
TKL Research, Inc.
Dermatology Consulting Services
Virginia Clinical Research, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers